Home › Funds › DEERFIELD MANAGEMENT COMPANY, L.P. › COGT

DEERFIELD MANAGEMENT COMPANY, L.P. position in COGT

COGENT BIOSCIENCES INC · Health Care

DEERFIELD MANAGEMENT COMPANY, L.P. reported holding 5,006,104 shares of COGT (COGENT BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$193.7M, representing 2.43% of its reported portfolio and ranking #8 among its reported holdings. DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed COGT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)5.01M sh
Reported value held$193.74M
Portfolio Weight2.43%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How DEERFIELD MANAGEMENT COMPANY, L.P.'s COGT position evolved

DEERFIELD MANAGEMENT COMPANY, L.P. first disclosed a stake in COGT in Q3 2023 at 1,089,345 shares (US$10.6M). The position peaked in Q1 2026 at 9,043,903 shares, worth US$348.1M. Across 12 filings, DEERFIELD MANAGEMENT COMPANY, L.P. increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 5,006,104 shares valued at US$193.7M — a reduction of -4,037,799 shares quarter over quarter.. Notable position changes include a 144% increase in Q2 2024 (shares rose 28% over the following quarter), a 243% increase in Q3 2025 (shares rose 147% over the following quarter), a 45% trim in Q2 2026 (shares fell 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.09M $10.62M New
Q4 2023 1.09M $6.41M Hold
Q1 2024 1.53M $10.31M Add
Q2 2024 3.74M $31.56M Add
Q3 2024 3.74M $40.44M Hold
Q4 2024 2.63M $20.52M Reduce
Q1 2025 2.63M $15.78M Hold
Q2 2025 2.64M $18.96M Hold
Q3 2025 9.05M $130.00M Add
Q4 2025 9.04M $321.24M Hold
Q1 2026 9.04M $348.10M Hold
Q2 2026 5.01M $193.74M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About COGT and 13F data

COGT (COGENT BIOSCIENCES INC) is a Health Care company. 59 other funds we track also report a position in COGT — the largest reported positions include Fairmount Funds Management LLC (US$213.0M), TCG Crossover Management, LLC (US$187.9M), Kynam Capital Management, LP (US$141.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding COGT

All COGT fund holders →

FAQ

How long has DEERFIELD MANAGEMENT COMPANY, L.P. held COGT?

DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed COGT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is DEERFIELD MANAGEMENT COMPANY, L.P.'s current position in COGT?

As of Q2 2026, DEERFIELD MANAGEMENT COMPANY, L.P. holds 5.01M shares of COGT (COGENT BIOSCIENCES INC), valued at $193.74M, representing 2.43% of its reported portfolio and ranking #8.

Has DEERFIELD MANAGEMENT COMPANY, L.P. been buying or selling COGT?

In the latest 13F filing (Q2 2026), DEERFIELD MANAGEMENT COMPANY, L.P. reduced its position in COGT. The position peaked in Q1 2026 at 9.04M shares.

Which other funds hold COGT?

Other major institutional holders of COGT include Fairmount Funds Management LLC, TCG Crossover Management, LLC, Kynam Capital Management, LP, among 59 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.